Business Wire

Cyta deploys ADVA Oscilloquartz solution for network timing

Share

ADVA (FSE: ADV) today announced the Cyprus Telecommunications Authority (Cyta) is leveraging its timing technology in a national synchronization network, addressing legacy timing applications and ensuring a smooth migration to precise packet timing for 5G critical services in the future. The solution enables Cyta to meet the stringent timing requirements of next-generation services while supporting all existing mobile technologies. ADVA’s Oscilloquartz PTP grandmaster clock and GNSS receiver technology not only enhances synchronization precision but also provides new levels of resilience and reliability. The project was facilitated by ADVA’s partners, the ICT solutions providers GCC Computers Ltd and ADAPTIT S.A., which will also provide ongoing technical support.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210713005088/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

ADVA’s synchronization technology is helping Cyta smoothly migrate to 5G services (Photo: Business Wire)

“Cyta now has a synchronization network able to address the accuracy, efficiency and stability demands of 5G. With support for NTP, PTP and SyncE, our technology ensures that the new infrastructure meets the needs of Cyta’s legacy applications, ensuring a smooth migration to the precise packet timing that is critical for 5G services,” said Hartmut Müller-Leitloff, SVP, sales, EMEA, ADVA. “Together with GCC’s and ADAPTIT S.A.’s teams, we’ve engineered a solution that fits Cyta’s exact requirements. It provides the sub-microsecond accuracy necessary for advanced mobile applications together with hardware redundancy for unbeatable resilience. What’s more, our Ensemble Controller network management technology makes it simple to operate.”

Prior to the deployment, Cyta’s timing network was based purely on frequency synchronization. It now distributes stable and accurate phase and time-of-day information, supporting the enhanced spectrum utilization needed for 5G. The solution features the OSA 5420 Series of grandmaster clocks, optimized for mobile backhaul and fronthaul in the radio access network. In the core, the OSA 5440 provides highest accuracy and availability with its dual multi-band, multi-constellation GNSS receiver and full hardware redundancy. The technology is remotely controlled by ADVA’s Ensemble Sync Director. This provides a powerful management platform, giving Cyta full visibility of its synchronization infrastructure and assuring perfect end-to-end timing.

“We’ve worked closely with Cyta to create a synchronization solution that fits its precise needs. Able to support both legacy and next-generation packet networking, Cyta’s new timing network is space- and power-efficient, assured by in-service PTP and GNSS monitoring and protected by hardware redundancy. Our engineers have also provided support at every stage of the process and made certain that the installation was carried out without any disruption to services,” commented Vasileios Karavasilis, commercial director, ADAPTIT S.A. “As a key distributor of ADVA’s Oscilloquartz solutions, we know all about the value of precise and reliable timing in mission-critical networks. Cyta is now prepared for mass 5G rollout with a synchronization architecture able to meet key challenges both now and in the future.”


About ADVA

ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com.

About Oscilloquartz

Oscilloquartz is a pioneer in time and frequency synchronization. We design, manufacture and deploy end-to-end synchronization systems that ensure the delivery and assurance of highly precise timing information over next-generation packet and legacy networks. As an ADVA company, we’re creating new opportunities for tomorrow’s networks. For more information, please visit us at www.oscilloquartz.com.

About GCC Computers Ltd.

GCC Computers has a distinguished market presence in Cyprus as an ICT System Integrator and has built a strong reputation as the employer of the best technology professionals. For more than 30 years, GCC has been acknowledged with considerable success serving Public/Government, Telecommunications & Utilities, Banking/Finance and SME (Small-Medium-Enterprise) sectors with innovative solutions. GCC’s expertise and extensive partnerships help clients harness the technology power to thrive on change and guide their digital transformation journeys. For more information, please visit us at www.gcc.com.cy.

About ADAPTIT S.A.

ADAPTIT S.A. is a highly specialized System Integrator that combines latest technology trends to offer its clients innovative tailor-made solutions, according to their needs, and finally delivers high-quality TURNKEY PROJECTS, ensuring the highest possible performance of their investment. With a wide-range portfolio of networking solutions ADAPTIT provides networking expertise to Service Providers, Government Agencies and Enterprises. ADAPTIT S.A. has presence in most European countries, having delivered similar major projects to several Service Providers in Spain, Sweden, Finland, Portugal, Poland, Romania, Malta, Bulgaria, and Albania. For more information, please visit us atwww.adaptit.gr.

About Cyta

Cyta is the leading provider of integrated electronic communications in Cyprus. Making the most of its technologically advanced networks, it offers a wide range of services and solutions to meet the ever-increasing demands of its residential and business customers for voice, data and content applications. With a pivotal role in the digital transformation of Cyprus, Cyta is deploying an island-wide, fiber-optic network, while it progressively upgrades its mobile network technology. It advances and maintains subsea and satellite networks for international connections of strategic importance that have established Cyprus as a regional telecommunications and connectivity hub in the Eastern Mediterranean.www.cyta.com.cy

Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For press:
Gareth Spence
t +44 1904 699 358
public-relations@adva.com

For investors:
Stephan Rettenberger
t +49 89 890 665 854
investor-relations@adva.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ADM Accelerates Growth of Leading Global Alternative Protein Platform with Planned Acquisition of Sojaprotein26.7.2021 14:05:00 CEST | Press release

Global nutrition leader ADM (NYSE: ADM) announced today that it has reached an agreement to acquire Sojaprotein, a leading European provider of non-GMO soy ingredients. Established in 1977, Serbia-based Sojaprotein has sales into 65 countries, offering a wide array of non-GMO vegetable protein ingredients for an extensive list of European and global customers in the meat alternative, confectionary, protein bar, pharmaceutical, pet food, and animal feed segments. The company had more than $100 million in sales in 2020. “Thirty years ago, ADM invented the soy vegetable burger, giving rise to the plant-based protein segment. Today, alternative proteins represents one of our core growth platforms, and as this $10 billion global industry grows to $30 billion over the next decade, we are investing to expand our unparalleled capabilities,” said Leticia Gonçalves, ADM’s president of Global Foods. “The addition of Sojaprotein – the largest producer of plant-based protein in southern Europe – ad

ABB to Divest Mechanical Power Transmission Division (Dodge) to RBC Bearings for $2.9 Billion26.7.2021 13:30:00 CEST | Press release

ABB today announced it has signed a definitive agreement to divest its Mechanical Power Transmission division (Dodge) to RBC Bearings Incorporated (Nasdaq: ROLL), for $2.9 billion in cash. The transaction will create a leading manufacturer of highly engineered, performance-critical bearings and motion control components. The transaction is expected to be completed by the end of the year 2021, subject to customary closing conditions, including regulatory review. For more than 140 years, the Dodge business has been a leader in the design, production, and marketing of mounted bearings, enclosed gearing, and power transmission components. It offers one of the broadest portfolios of mechanical power transmission products in the market, selling to industries such as surface mining, aggregates & cement, warehousing and food & beverage. Dodge has roughly 1,500 employees worldwide and achieved revenues of approximately $600 million for the last twelve months ending June 30, 2021, of which more

CHMP grants positive opinion in the European Union for Otsuka’s child-friendly 25 mg dispersible tablet formulation of Deltyba ® (delamanid) for the paediatric population weighing at least 10 kg with pulmonary multi-drug resistant tuberculosis26.7.2021 12:00:00 CEST | Press release

Otsuka Novel Products GmbH (ONPG), a subsidiary of Otsuka Pharmaceutical Co., Ltd., is pleased to announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommends approval of Deltyba 25 mg dispersible tablets (delamanid) for use as part of an appropriate combination regimen for pulmonary MDR-TB in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability. The current World Health Organization Global TB Report estimates that 1.2 million children (0-14 years of age) fell ill with TB in 2019.2 According to a scientific publication, every year approximately 25,000-32,000 children world-wide fall ill with MDR-TB. Of these, only a few are diagnosed and treated successfully and approximately 21% of children with MDR-TB are likely to die.1 New global targets set at the UN’s High Level Meeting on TB in 2018 inclu

First-of-Its-Kind “Pathways to Dairy Net Zero” Initiative to Raise Climate Ambition for the Global Dairy Sector26.7.2021 11:00:00 CEST | Press release

Afirst-of-its-kind Pathways to Dairy Net Zero initiative is being developed to accelerate climate change action throughout the global dairy sector. Announced today at the United Nations (UN) Food Systems Pre-Summit, the climate effort will be unlike any other in agriculture in terms of size, breadth, and scope. “The global dairy sector is creating this ground-breaking initiative to help speed climate action already underway, while continuing to provide livelihoods for a billion people and important nutrition for six billion people,” said Donald Moore, Executive Director at the Global Dairy Platform. A multi-stakeholder group of organizations, including the global dairy sector and representatives from the scientific and research communities, are working together to develop methodologies, tools and pathways that work for every dairy system. Pathways to Dairy Net Zero will officially launch during the UN Food Systems Summit in September and aims to generate commitments at the UN Climate C

Santen and IAPB Taking Action to Implement the First Ever UN General Assembly Resolution Recognizing the Link Between Eye Health and Sustainable Development26.7.2021 09:00:00 CEST | Press release

Santen Pharmaceutical Co., Ltd. (“Santen”) announced today that Santen, in partnership with the International Agency for the Prevention of Blindness (IAPB), will take action to implement United Nations General Assembly Resolution A/75/L.108 on eye health. This comes after several months of collaboration with the IAPB, advocating for global action to improve access to basic eye health services. Santen is committed to reducing the loss of social and economic opportunities for people living with eye conditions. The new UN General Assembly resolution encourages governments and key stakeholders from around the world to mobilize the necessary resources to address this urgent priority. UN entities including UNICEF, UN-Women, UNDP, UNESCO, the International Labor Organization and the UN Road Safety Collaboration will work to promote and include eye health in their work. International financial institutions and donors will be urged to include eye health priorities in their funding programs. We

HKTDC Twin Jewellery Events Open in Hong Kong26.7.2021 08:52:00 CEST | Press release

The HKTDCHong Kong International Jewellery Show and HKTDC Hong Kong International Diamond, Gem & Pearl Show, opened on 25 July at the Hong Kong Convention and Exhibition Centre (HKCEC) and will run until 29 July. The twin shows are the first two physical trade fairs to be staged by the Hong Kong Trade Development Council (HKTDC), since the pandemic began and are being held in a hybrid format for the first time, with both physical and online exhibitions. The online show will run until 5 August to help global jewellers capture business opportunities as the pandemic continues. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210725005042/en/ The HKTDC Hong Kong International Jewellery Show and the HKTDC Hong Kong International Diamond, Gem & Pearl Show, organised by the Hong Kong Trade Development Council (HKTDC), take place on 25-29 July 2021 at the Hong Kong Convention and Exhibition Centre (HKCEC), helping jewellers capture bu

Women in India are the first in the world to receive new heat-stable carbetocin formulation to prevent excessive bleeding after childbirth26.7.2021 08:30:00 CEST | Press release

After nearly a decade of public-private collaboration, Ferring Pharmaceuticals today announces the first use of heat-stable carbetocin (Carbetocin Ferring) for the prevention of excessive bleeding after birth, known as postpartum haemorrhage (PPH). Heat-stable carbetocin is now available for use in healthcare facilities across India, in the prevention of excessive bleeding following vaginal and caesarean section births. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210725005005/en/ Sarika – the first woman to receive heat-stable carbetocin, with her husband, newborn son and the first doctor to administer, Dr Yeshita V Pujar, Karnataka, India (Photo: Business Wire) This major maternal health milestone has been eagerly awaited since the publication of the CHAMPION (Carbetocin HAeMorrhage PreventION) trial results in 20182 - a study led by the World Health Organization (WHO) as part of a collaboration with MSD for Mothers* and